The complex [Cr(tpy)(O3SCF3)3] (tpy = 2,2':6',2''-terpyridine) is readily made from [Cr(tpy)Cl3] and is a convenient precursor to [Cr(tpy)2][PF6]3 and to [Cr(tpy)(4'-(4-tolyl)tpy)][PF6]3 and [Cr(tpy)(5,5''-Me2tpy)][PF6]3 (4'-(4-tolyl)tpy = 4'-(4-tolyl)-2,2':6',2''-terpyridine; 5,5''-Me2tpy = 5,5''-dimethyl-2,2':6',2''-terpyridine); these are the first examples of heteroleptic bis(tpy) chromium(III) complexes. The single crystal structures of 2{[Cr(tpy)2][PF6]3}·5MeCN, [Cr(tpy)(4'-(4-tolyl)tpy)][PF6]3·3MeCN and [Cr(tpy)(5,5''-Me2tpy)][PF6]3·3MeCN have been determined. Each cation contains the expected octahedral {Cr(tpy)2}(3+) unit; in all three structures, the need to accommodate three anions per cation and the solvent molecules prevents the formation of a grid-like array of cations that is typical of many lattices containing {M(tpy)2}(2+) motifs. Three reversible electrochemical processes are observed for [Cr(tpy)(4'-(4-tolyl)tpy)][PF6]3 and [Cr(tpy)(5,5''-Me2tpy)][PF6]3, consistent with those documented for [Cr(tpy)2](3+). At pH 6.36, aqueous solutions of [Cr(tpy)2][PF6]3 are stable for at least two months. However, contrary to the expectations of the d(3) Cr(3+) ion being a kinetically inert metal centre, the tpy ligands in [Cr(tpy)2](3+) are labile in the presence of base; absorption and (1)H NMR spectroscopies have been used to monitor the effects of adding NaOH to aqueous and CD3OD solutions, respectively, of the homo- and heteroleptic complexes. Ligand dissociation is also observed when [Bu4N]F is added to CD3OD solutions of the complexes, but in aqueous solution, [Cr(tpy)2][PF6]3 is stable in the presence of fluoride ion.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c4dt00200h | DOI Listing |
Eur J Pharmacol
April 2022
Faculty of Veterinary, State University of Ceará, 60714-903, Fortaleza, Ceará, Brazil.
Metal coordination complexes are chemotherapeutic and anti-inflammatory agents. The ruthenium complex FOR811A ([Ru(bpy)(2-MIM)Cl](PF)) FOR811A was evaluated in mice models of acute inflammation and behavioral tests. Animals received FOR811A (3, 10 or 30 mg/kg; i.
View Article and Find Full Text PDFDalton Trans
July 2021
Diffraction & Scattering Division, Japan Synchrotron Radiation Research Institute(JASRI), 1-1-1 Kouto, Sayo-cho, Sayo-gun, Hyogo 679-5198, Japan and Institute for Integrated Cell-Material Sciences (iCeMS), Institute for Advance Study (KUIAS), Kyoto University, Kyoto, Japan.
The biscatechol, H4BP (4,4'-bis(3-tert-butyl-1,2-catechol)) that can directly connect two redox active catechol moieties was synthesized. Also, tris(2-pyridylmethyl)amine (tpa), bis(2-pyridylmethyl)(2-quinolylmethyl)amine (bpqa), (2-pyridylmethyl)bis(2-quinolyl methyl)amine (pbqa), and tris (2-quinolylmethyl)amine (tqa) were synthesized as terminal ligands of the tetracoordinated tripod. In total, five different dinuclear Co complexes were synthesized from H4BP with various terminal ligands as follows, [Co2(BP)(tpa)2](PF6)2 (1), [Co2(BP)(tpa)2](PF6)3 (2), [Co2(BP)(bpqa)2](PF6)2 (3), [Co2(BP)(pbqa)2](PF6)2 (4), and [Co2(BP)(tqa)2](PF6)2 (5).
View Article and Find Full Text PDFPLoS One
October 2021
Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
We aimed at evaluating the anti-asthmatic effect of cis-[Ru(bpy)2(2-MIM)(NO)](PF6)3 (FOR811A), a nitrosyl-ruthenium compound, in a murine model of allergic asthma. The anti-asthmatic effects were analyzed by measuring the mechanical lung and morphometrical parameters in female Swiss mice allocated in the following groups: untreated control (Ctl+Sal) and control treated with FOR811A (Ctl+FOR), along asthmatic groups untreated (Ast+Sal) and treated with FOR811A (Ast+FOR). The drug-protein interaction was evaluated by in-silico assay using molecular docking.
View Article and Find Full Text PDFDalton Trans
February 2021
Department of Materials Science, Graduate School of Nanobioscience, Yokohama City University, 22-2 Seto, Kanazawa-ku, Yokohama 236-0027, Japan.
[Ir(tpy)2](PF6)3 (tpy = 2,2':6',2''-terpyridine) dissolved in CH3CN was found to exhibit dual color luminescent emission depending on the excitation wavelength. Specifically, blue and green emissions were obtained with excitation at 350 and 410 nm, respectively. Because the associated emission spectra were consistent with those of [Ir(tpy)2]Cl3 in water and [Ir(tpy)2](PF6)3 in the crystalline state, respectively, this dual emission is attributed to emissions from the [Ir(tpy)2]3+ cation and its ion pair [Ir(tpy)2]3+·PF6-.
View Article and Find Full Text PDFDalton Trans
August 2020
Department of Chemistry, Indian Institute of Technology, Hyderabad, Kandi, Sangareddy 502285, Telangana, India.
Polypyridyl backbone nitrosyl complexes of ruthenium with the molecular framework [RuII(antpy)(bpy)NO+/˙]n+ [4](PF6)3 (n = 3), [4](PF6)2 (n = 2), where antpy = 4'-(anthracene-9-yl)-2,2':6',2''-terpyridine and bpy = 2,2'-bipyridine, were synthesized via a stepwise synthetic route from the chloro precursor [RuII(antpy)(bpy)(Cl)](PF6) [1](PF6) and [RuII(antpy)(bpy)(CH3CN)](PF6)2 [2](PF6)2 and [RuII(antpy)(bpy)(NO2)](PF6) [3](PF6). After column chromatographic purification, all the synthesized complexes were fully characterized using different spectroscopic and analytical techniques including mass spectroscopy, 1H NMR, FT-IR and UV-vis spectrophotometry. The Ru-NO stretching frequency of [4](PF6)3 was observed at 1941 cm-1, which suggests moderately strong Ru-NO bonding.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!